Welcome to Sysmex Blogs

This article explores the growing impact of liquid biopsy in routine clinical practice – highlighting how it has been integrated into patient management across various cancer types and revealing its value across a wider range of real-world settings.

Breast cancer is one of the most common types of cancer affecting women worldwide. In hormone receptor-positive, HER2-negative metastatic breast cancer, endocrine treatment has led to significant improvement in patient’s condition. However, tumors can develop resistance mechanisms throughout the therapy, for example via activating mutations in ESR1.

Liquid biopsy offers a non-invasive method for detecting ESR1 mutations

As we enjoy the summer and raise awareness about melanoma, this month's Impact discusses the latest scientific data on patient management. Hear directly from Dr. Isabel Heidrich and Dr. Christoffer Gebhardt about how liquid biopsy can be a valuable ally in the fight against melanoma.

Bereits an der Produktkennzeichnung kann erkannt werden, ob ein IVD-Produkt die strengen IvDV-Anforderungen in der Schweiz erfüllt. Hier einige wesentliche Merkmale.